India’s food safety regulator has found a sample of Nestlé’s infant follow-up formula to be substandard for its biotin content and has initiated legal action against the company. The Food Safety and Standards Authority of India (FSSAI) said a re-analysis of the sample found it did not meet the prescribed biotin requirements under Indian regulations. […]Continue Reading
